Annual Total Liabilities
$2.63 M
+$723.60 K+37.92%
December 31, 2023
Summary
- As of February 8, 2025, LPCN annual total liabilities is $2.63 million, with the most recent change of +$723.60 thousand (+37.92%) on December 31, 2023.
- During the last 3 years, LPCN annual total liabilities has fallen by -$7.38 million (-73.71%).
- LPCN annual total liabilities is now -80.32% below its all-time high of $13.37 million, reached on December 31, 2019.
Performance
LPCN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.58 M
-$242.70 K-13.31%
September 30, 2024
Summary
- As of February 8, 2025, LPCN quarterly total liabilities is $1.58 million, with the most recent change of -$242.70 thousand (-13.31%) on September 30, 2024.
- Over the past year, LPCN quarterly total liabilities has dropped by -$1.05 million (-39.91%).
- LPCN quarterly total liabilities is now -89.46% below its all-time high of $15.01 million, reached on March 31, 2018.
Performance
LPCN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LPCN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.9% | -39.9% |
| 3 y3 years | -73.7% | -18.1% |
| 5 y5 years | -77.0% | -18.1% |
LPCN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.9% | +37.9% | -77.1% | +6.1% |
| 5 y | 5-year | -80.3% | +37.9% | -89.0% | +6.1% |
| alltime | all time | -80.3% | >+9999.0% | -89.5% | >+9999.0% |
Lipocine Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.58 M(-13.3%) |
| Jun 2024 | - | $1.82 M(+22.4%) |
| Mar 2024 | - | $1.49 M(-43.4%) |
| Dec 2023 | $2.63 M(+37.9%) | $2.63 M(+15.9%) |
| Sep 2023 | - | $2.27 M(+17.6%) |
| Jun 2023 | - | $1.93 M(-6.3%) |
| Mar 2023 | - | $2.06 M(+8.1%) |
| Dec 2022 | $1.91 M(-72.4%) | $1.91 M(+7.5%) |
| Sep 2022 | - | $1.78 M(-22.9%) |
| Jun 2022 | - | $2.30 M(-55.6%) |
| Mar 2022 | - | $5.19 M(-24.9%) |
| Dec 2021 | $6.91 M(-31.0%) | $6.91 M(-8.8%) |
| Sep 2021 | - | $7.58 M(-33.7%) |
| Jun 2021 | - | $11.43 M(+39.7%) |
| Mar 2021 | - | $8.19 M(-18.2%) |
| Dec 2020 | $10.01 M(-25.1%) | $10.01 M(-2.3%) |
| Sep 2020 | - | $10.24 M(-1.5%) |
| Jun 2020 | - | $10.40 M(-28.0%) |
| Mar 2020 | - | $14.44 M(+8.0%) |
| Dec 2019 | $13.37 M(+17.1%) | $13.37 M(+35.9%) |
| Sep 2019 | - | $9.84 M(+0.1%) |
| Jun 2019 | - | $9.83 M(-5.9%) |
| Mar 2019 | - | $10.44 M(-8.6%) |
| Dec 2018 | $11.42 M | $11.42 M(+4.5%) |
| Sep 2018 | - | $10.92 M(-4.4%) |
| Jun 2018 | - | $11.42 M(-23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $15.01 M(+136.5%) |
| Dec 2017 | $6.35 M(+378.4%) | $6.35 M(+155.4%) |
| Sep 2017 | - | $2.48 M(-14.3%) |
| Jun 2017 | - | $2.90 M(+23.7%) |
| Mar 2017 | - | $2.35 M(+76.8%) |
| Dec 2016 | $1.33 M(-60.9%) | $1.33 M(-15.6%) |
| Sep 2016 | - | $1.57 M(-39.2%) |
| Jun 2016 | - | $2.58 M(-13.7%) |
| Mar 2016 | - | $2.99 M(-11.7%) |
| Dec 2015 | $3.39 M(+107.6%) | $3.39 M(+55.7%) |
| Sep 2015 | - | $2.18 M(+30.9%) |
| Jun 2015 | - | $1.67 M(+24.5%) |
| Mar 2015 | - | $1.34 M(-18.1%) |
| Dec 2014 | $1.63 M(+27.2%) | $1.63 M(-20.6%) |
| Sep 2014 | - | $2.06 M(+23.1%) |
| Jun 2014 | - | $1.67 M(+11.4%) |
| Mar 2014 | - | $1.50 M(+16.8%) |
| Dec 2013 | $1.28 M(>+9900.0%) | $1.28 M(-21.2%) |
| Sep 2013 | - | $1.63 M(+9151.7%) |
| Jun 2013 | - | $17.60 K(+17.3%) |
| Mar 2013 | - | $15.00 K(+26.1%) |
| Dec 2012 | $11.90 K(+56.6%) | $11.90 K(+70.0%) |
| Sep 2012 | - | $7000.00(+70.7%) |
| Jun 2012 | - | $4100.00(-44.6%) |
| Mar 2012 | - | $7400.00 |
| Dec 2011 | $7600.00 | - |
FAQ
- What is Lipocine annual total liabilities?
- What is the all time high annual total liabilities for Lipocine?
- What is Lipocine annual total liabilities year-on-year change?
- What is Lipocine quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lipocine?
- What is Lipocine quarterly total liabilities year-on-year change?
What is Lipocine annual total liabilities?
The current annual total liabilities of LPCN is $2.63 M
What is the all time high annual total liabilities for Lipocine?
Lipocine all-time high annual total liabilities is $13.37 M
What is Lipocine annual total liabilities year-on-year change?
Over the past year, LPCN annual total liabilities has changed by +$723.60 K (+37.92%)
What is Lipocine quarterly total liabilities?
The current quarterly total liabilities of LPCN is $1.58 M
What is the all time high quarterly total liabilities for Lipocine?
Lipocine all-time high quarterly total liabilities is $15.01 M
What is Lipocine quarterly total liabilities year-on-year change?
Over the past year, LPCN quarterly total liabilities has changed by -$1.05 M (-39.91%)